Orthopedic Device Market Trends: What Reps Need to Know in 2026
By Joshua Dunn, Founder · March 22, 2026 · 9 min read · Industry Insights
The Orthopedic Market in 2026: A $65 Billion Opportunity
The global orthopedic device market is projected to reach $65 billion by the end of 2026, driven by an aging population, rising obesity rates, active lifestyle injuries, and technological innovation. For medical sales reps, orthopedics remains one of the most lucrative specialties, but the landscape is shifting in ways that will reward adaptable reps and punish those who rely on legacy relationships alone.
Trend 1: Robotic-Assisted Surgery Goes Mainstream
Robotic platforms for joint replacement, spine surgery, and sports medicine are no longer limited to academic medical centers. Mid-size hospitals and ambulatory surgery centers are investing in robotic systems, creating opportunities for reps who understand the technology. Key platforms to watch include Stryker's Mako, Zimmer Biomet's ROSA, and Smith+Nephew's CORI. If you sell orthopedic implants, understanding how your products integrate with robotic platforms is becoming essential.
Trend 2: Biologics and Regenerative Medicine
The biologics segment is growing at 8-10% annually, outpacing traditional implant growth. Products like bone grafts, platelet-rich plasma (PRP) systems, stem cell therapies, and cartilage repair solutions are creating new revenue streams for reps. This category offers several advantages for independent reps:
- Lower capital requirements than implant inventory management
- Strong recurring revenue from consumable products
- Applicability across multiple orthopedic subspecialties
- Growing physician interest driven by patient demand for minimally invasive options
Trend 3: Outpatient Joint Replacement
CMS removed total knee replacement from the inpatient-only list in 2020, and total hip replacement followed in 2021. The migration of joint replacement procedures to ambulatory surgery centers continues to accelerate. For reps, this means:
- New customer targets: ASCs performing joint replacements need implant systems, instrumentation, and surgical supplies.
- Price sensitivity: ASCs operate on tighter margins than hospitals. Pricing flexibility and value propositions focused on efficiency are critical.
- Streamlined inventory: ASCs prefer implant systems with fewer tray sizes and simplified instrumentation. Products designed for outpatient efficiency have a competitive advantage.
Trend 4: Data-Driven Outcomes and Registry Participation
Surgeons and hospital systems increasingly demand implant-level outcomes data. National registries like the American Joint Replacement Registry (AJRR) track implant survival rates, complication rates, and revision data. Manufacturers whose products have strong registry data have a significant selling advantage. As a rep, be prepared to discuss your product's real-world outcomes data, not just clinical trial results. Registry performance is becoming a key differentiator in purchasing decisions.
The orthopedic market rewards reps who stay ahead of trends and continuously evolve their knowledge. Whether you specialize in joints, spine, sports medicine, or trauma, understanding these market dynamics will help you position your products and your business for sustained growth.